Breaking News

Recent Posts

AstraZeneca gets EU backing for targeted breast cancer therapies

AstraZeneca said on Monday two of its existing therapies were recommended for treating patients with some forms of high-risk breast cancers in the European Union, in a boost to the company’s oncology portfolio. Lynparza, a cancer drug developed jointly with U.S.-based Merck, was backed for standalone use or in combination …

Read More »